These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 3531574

  • 1. [Progress in chemotherapeutic agents--beta-lactam antibiotics and beta-lactamase inhibitors].
    Uzuka Y, Matsumoto K.
    Nihon Rinsho; 1986 Apr; 44(4):824-30. PubMed ID: 3531574
    [No Abstract] [Full Text] [Related]

  • 2. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
    Tamura M, Ito T.
    Nihon Rinsho; 1987 Mar; 45(3):583-7. PubMed ID: 3037135
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Parenteral beta-lactamase inhibitor combinations for clinical use.
    Manzella JP.
    Am Fam Physician; 1995 May 15; 51(7):1695-8. PubMed ID: 7754928
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of augmentin on sputum beta-lactamase activity in patients with cystic fibrosis.
    Penketh AR, Hodson ME, Batten JC.
    Br J Clin Pract; 1984 May 15; 38(5):188-9. PubMed ID: 6610437
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and clinical studies on timentin in ear, nose and throat infections.
    Federspil P, Koch A, Schedler M, Tiesler E.
    J Chemother; 1989 Jul 15; 1(4 Suppl):500-1. PubMed ID: 16312503
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Therapy of infective respiratory diseases with a shielded beta-lactam antibiotic (amoxicillin and clavulanic acid)].
    Palermo B, Rizza S, Pistorio MP, Crimi N, Maccarrone C, Mistretta A.
    Arch Monaldi Mal Torace; 1987 Jul 15; 42(6):519-33. PubMed ID: 3334115
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections.
    Tan TH, Tay L, Yeo M, Feng PH.
    Singapore Med J; 1983 Oct 15; 24(5):299-302. PubMed ID: 6669995
    [No Abstract] [Full Text] [Related]

  • 14. Augmentin treatment of bacterial infections in hospitalised patients.
    Ellis-Pegler RB, Lang SD, Downey DJ, Anderson MP.
    N Z Med J; 1982 Aug 11; 95(713):542-5. PubMed ID: 6752781
    [Abstract] [Full Text] [Related]

  • 15. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
    Parker RH, Eggleston M.
    Infect Control; 1987 Jan 11; 8(1):36-40. PubMed ID: 3028975
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An initial assessment of augmentin for the treatment of paediatric infections in general practice.
    Jeffries MG, Rose AJ, Williams HN.
    Br J Clin Pract; 1983 Feb 11; 37(2):61-6. PubMed ID: 6860540
    [No Abstract] [Full Text] [Related]

  • 19. Evolution of beta-lactamase inhibitors.
    Rolinson GN.
    Surg Gynecol Obstet; 1991 Feb 11; 172 Suppl():11-6. PubMed ID: 2024221
    [Abstract] [Full Text] [Related]

  • 20. Implications of beta-lactamase-inhibitor combinations.
    Jones RN.
    J Reprod Med; 1988 Jun 11; 33(6 Suppl):574-8. PubMed ID: 3294402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.